The consideration payable by the company under the Panaxia transaction was CA$7.2 million ($5.3 million), comprised of CA$2.9 million in cash, payable in two installments, and $4.3 million in common shares, payable in five installments. To date, the company preformed four installments.
The Panaxia transaction included a further option to acquire, for no additional consideration, a pharmacy, including requisite licenses to dispense and sell medical cannabis to patients.
Price Action
IM Cannabis shares were trading 4.8% higher at $1.069 per share at the time of writing Monday morning.
Benzinga's Cannabis Capital Conference Is Back
Photo: Benzinga edit with photos by Matthias Zomer on Pexels and squarefrog on Pixabay
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
